Amifostine Ethiofos
Brand names,
Amifostine Ethiofos
Analogs
Amifostine Ethiofos
Brand Names Mixture
Amifostine Ethiofos
Chemical_Formula
C5H15N2O3PS
Amifostine Ethiofos
RX_link
http://www.rxlist.com/cgi/generic/amifostine.htm
Amifostine Ethiofos
fda sheet
Amifostine Ethiofos
msds (material safety sheet)
Amifostine Ethiofos
Synthesis Reference
No information avaliable
Amifostine Ethiofos
Molecular Weight
214.224 g/mol
Amifostine Ethiofos
Melting Point
No information avaliable
Amifostine Ethiofos
H2O Solubility
1000 mg/mL
Amifostine Ethiofos
State
Solid
Amifostine Ethiofos
LogP
-1.043
Amifostine Ethiofos
Dosage Forms
Powder for solution
Amifostine Ethiofos
Indication
For reduction in the cumulative renal toxicity in patients with ovarian cancer (using cisplatin) and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.
Amifostine Ethiofos
Pharmacology
Amifostine is an organic thiophosphate cytoprotective agent indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer or non-small cell lung cancer and also to reduce the incidence of moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer. Amifostine is a prodrug that is dephosphorylated by alkaline phosphatase in tissues to a pharmacologically active free thiol metabolite, believed to be responsible for the reduction of the cumulative renal toxicity of cisplatin and for the reduction of the toxic effects of radiation on normal oral tissues. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Amifostine Ethiofos
Absorption
No information avaliable
Amifostine Ethiofos
side effects and Toxicity
Rat LD50: 826 mg/kg
Amifostine Ethiofos
Patient Information
No information avaliable
Amifostine Ethiofos
Organisms Affected
Humans and other mammals